Healthcare Press

FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortage

  • 📰 CNBC
  • ⏱ Reading Time:
  • 8 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 72%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The FDA has given Qilu Pharmaceutical permission to ship cisplatin to the U.S. to ease a national cancer drug shortage.

A letter dated May 24 from Qilu's deputy general manager notified health-care professionals of the approval.

Qilu, which is headquartered in the city of Jinan in Shandong province, says it is one of the 10 largest drug manufacturers in China.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Shortage of lifesaving chemo drugs adds to cancer patients' fearsThe FDA says more than a dozen cancer drugs are in short supply, including Carboplatin.
Source: fox5ny - 🏆 587. / 51 Read more »